{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:21:43Z","timestamp":1783351303133,"version":"3.54.6"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Technological advancement and industrialization have significantly increased human exposure to xenobiotics, a diverse group of foreign chemical substances with potential toxic effects. Xenobiotics include pharmaceuticals, pesticides, personal care products, industrial chemicals, and environmental pollutants. The liver, as the primary organ responsible for biotransformation, plays a central role in the detoxification and activation of these compounds. However, metabolic processes may generate reactive intermediates that contribute to hepatocellular injury. This review provides a comprehensive overview of xenobiotic classification, mechanisms of hepatic biotransformation, and the molecular pathways underlying xenobiotic-induced hepatotoxicity. Special emphasis is placed on oxidative stress, reactive metabolite formation, and immune-mediated mechanisms. Clinical manifestations, diagnostic approaches, and current management strategies are also discussed. Understanding these processes is essential for early detection, prevention, and improved therapeutic outcomes in patients with xenobiotic-induced liver injury..<\/jats:p>","DOI":"10.2478\/prilozi-2026-0024","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:08:51Z","timestamp":1783350531000},"page":"111-124","source":"Crossref","is-referenced-by-count":0,"title":["Xenobiotics Induced Liver Toxicity"],"prefix":"10.2478","volume":"47","author":[{"given":"Kalina","family":"Gjorgjievska","sequence":"first","affiliation":[{"name":"1 University of Ss. Cyril and Methodius , Faculty of Medicine, Institute of Preclinical and Clinical Pharmacology and Toxicology , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pavlovska","sequence":"additional","affiliation":[{"name":"1 University of Ss. Cyril and Methodius , Faculty of Medicine, Institute of Preclinical and Clinical Pharmacology and Toxicology , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragica","family":"Zendelovska","sequence":"additional","affiliation":[{"name":"1 University of Ss. Cyril and Methodius , Faculty of Medicine, Institute of Preclinical and Clinical Pharmacology and Toxicology , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilija","family":"Atanasovska","sequence":"additional","affiliation":[{"name":"1 University of Ss. Cyril and Methodius , Faculty of Medicine, Institute of Preclinical and Clinical Pharmacology and Toxicology , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Petrushevska","sequence":"additional","affiliation":[{"name":"1 University of Ss. Cyril and Methodius , Faculty of Medicine, Institute of Preclinical and Clinical Pharmacology and Toxicology , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026070615002480558_j_prilozi-2026-0024_ref_001","doi-asserted-by":"crossref","unstructured":"\u0160tefanac T, Grgas D, Landeka Dragi\u010devi\u0107 T. Xenobiotics-Division and Methods of Detection: A Review. J Xenobiot. 2021;11(4):130-141. DOI: 10.3390\/jox11040009.","DOI":"10.3390\/jox11040009"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_002","unstructured":"Hodgson E. Introduction to Toxicology. A Textbook of Modern Toxicology. 3rd ed. John Wiley & Sons, Ltd; 2004.p. 75-110. DOI: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/0471646776.ch6"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_003","doi-asserted-by":"crossref","unstructured":"de Oliveira M, Frihling BEF, Velasques J, Filho FJCM, Cavalheri PS, Migliolo L. Pharmaceuticals residues and xenobiotics contaminants: Occurrence, analytical techniques and sustainable alternatives for wastewater treatment. Sci. Total Environ. 2020; 705:135568. DOI: 10.1016\/j.scitotenv.2019.135568.","DOI":"10.1016\/j.scitotenv.2019.135568"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_004","doi-asserted-by":"crossref","unstructured":"Attia SM. Deleterious effects of reactive metabolites. Oxid Med Cell Longev. 2010; 3(4):238-253. DOI:10.4161\/oxim.3.4.13246","DOI":"10.4161\/oxim.3.4.13246"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_005","doi-asserted-by":"crossref","unstructured":"Stapleton PA, Abukabda AB, Hardy SL, Nurkiewicz TR. Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links. Am J Physiol Heart Circ Physiol. 2015; 309(10):H1609-H1620. DOI:10.1152\/ajpheart.00546.2015","DOI":"10.1152\/ajpheart.00546.2015"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_006","doi-asserted-by":"crossref","unstructured":"Vojdani A. A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis. 2014; 2014:437231. DOI:10.1155\/2014\/437231","DOI":"10.1155\/2014\/437231"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_007","doi-asserted-by":"crossref","unstructured":"Virolainen SJ, VonHandorf A, Viel KCMF, Weirauch MT, Kottyan LC. Gene-environment interactions and their impact on human health. Genes Immun. 2023; 24(1):1-11. DOI:10.1038\/s41435-022-00192-6","DOI":"10.1038\/s41435-022-00192-6"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_008","doi-asserted-by":"crossref","unstructured":"Xuan L, Ju Z, Skonieczna M, Zhou PK, Huang R. Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models. MedComm (2020). 2023; 4(4):e327. DOI:10.1002\/mco2.327","DOI":"10.1002\/mco2.327"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_009","doi-asserted-by":"crossref","unstructured":"Idle JR, Gonzalez FJ. Metabolomics. Cell Metab. 2007; 6(5):348-351. DOI:10.1016\/j. cmet.2007.10.005","DOI":"10.1016\/j.cmet.2007.10.005"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_010","doi-asserted-by":"crossref","unstructured":"Esteves F, Rueff J, Kranendonk M. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family. J Xenobiot. 2021; 11(3):94-114. DOI:10.3390\/jox11030007","DOI":"10.3390\/jox11030007"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_011","doi-asserted-by":"crossref","unstructured":"Feng J, Cerniglia CE, Chen H. Toxicological significance of azo dye metabolism by human intestinal microbiota. Front Biosci (Elite Ed). 2012; 4(2):568-586. DOI:10.2741\/e400","DOI":"10.2741\/e400"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_012","unstructured":"Long J, Zhang CJ, Zhu N, et al. Lipid metabolism and carcinogenesis, cancer development. Am J Cancer Res. 2018; 8(5):778-791."},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_013","doi-asserted-by":"crossref","unstructured":"Baynes R, Hodgson E. Absorption and Distribution of Toxicants. A Textbook of Modern Toxicology. 3rd ed. John Wiley & Sons, Ltd; 2004.p. 75-110. DOI: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/0471646776.ch6","DOI":"10.1002\/0471646776.ch6"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_014","doi-asserted-by":"crossref","unstructured":"Gu X, Manautou JE. Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med. 2012; 14:e4. Published 2012 Feb 3. DOI: 10.1017\/S1462399411002110","DOI":"10.1017\/S1462399411002110"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_015","doi-asserted-by":"crossref","unstructured":"Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010; 62(1):1-96. DOI:10.1124\/pr.109.002014","DOI":"10.1124\/pr.109.002014"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_016","doi-asserted-by":"crossref","unstructured":"Genuis SJ. Elimination of persistent toxicants from the human body. Hum Exp Toxicol. 2011; 30(1):3-18. DOI: 10.1177\/0960327110368417","DOI":"10.1177\/0960327110368417"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_017","doi-asserted-by":"crossref","unstructured":"Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013; 173(5):355-361. DOI:10.1001\/jamainternmed.2013.2299","DOI":"10.1001\/jamainternmed.2013.2299"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_018","doi-asserted-by":"crossref","unstructured":"G\u00fcnalan E, Cebio\u011flu \u0130K, \u00c7onak \u00d6. The Popularity of the Biologically-Based Therapies During Coronavirus Pandemic Among the Google Users in the USA, UK, Germany, Italy and France. Complement Ther Med. 2021;58:102682. DOI:10.1016\/j.ctim.2021.102682","DOI":"10.1016\/j.ctim.2021.102682"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_019","doi-asserted-by":"crossref","unstructured":"van Breemen RB. Development of Safe and Effective Botanical Dietary Supplements. J Med Chem. 2015; 58(21):8360-8372. DOI:10.1021\/acs.jmedchem.5b00417","DOI":"10.1021\/acs.jmedchem.5b00417"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_020","unstructured":"Directive 2004\/24\/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001\/83\/EC on the Community code relating to medicinal products for human use [Internet]. 2004. Available from: http:\/\/data.europa.eu\/eli\/dir\/2004\/24\/oj [Accessed: 2024-08-05]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_021","unstructured":"Consolidated text: Regulation (EC) No 1924\/2006 of the european parliament and of the council of 20 December 2006 on nutrition and health claims made on foods [Internet]. 2014. Available from http:\/\/data.europa.eu\/eli\/reg\/2006\/1924\/2014-12-13 [Accessed: 2024-08-06]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_022","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Cort\u00e9s M, Robles-D\u00edaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ. Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics. Int J Mol Sci. 2016;17(4):537. DOI:10.3390\/ijms17040537","DOI":"10.3390\/ijms17040537"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_023","doi-asserted-by":"crossref","unstructured":"Brown AC. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food Chem Toxicol. 2017;107(Pt A):472-501. DOI:10.1016\/j. fct.2016.07.001","DOI":"10.1016\/j.fct.2016.07.001"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_024","doi-asserted-by":"crossref","unstructured":"Petrovic A, Vukadin S, Sikora R, et al. Anabolic androgenic steroid-induced liver injury: An update. World J Gastroenterol. 2022;28(26):3071-3080. DOI:10.3748\/wjg.v28.i26.3071","DOI":"10.3748\/wjg.v28.i26.3071"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_025","doi-asserted-by":"crossref","unstructured":"Ciuc\u0103 Anghel DM, Ni\u021bescu GV, Tiron AT, Gu\u021bu CM, Baconi DL. Understanding the Mechanisms of Action and Effects of Drugs of Abuse. Molecules. 2023;28(13):4969. DOI:10.3390\/molecules28134969","DOI":"10.3390\/molecules28134969"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_026","unstructured":"Roy DN, Goswami R. Drugs of abuse and addiction: A slippery slope toward liver injury. Chem Biol Interact. 2016;255:92-105. DOI:10.1016\/j. cbi.2015.09.018"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_027","unstructured":"Patel R, Mueller M. Alcoholic Liver Disease. [Internet]. StatPearls Publishing 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546632\/[ Accessed: 2024-08-26]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_028","doi-asserted-by":"crossref","unstructured":"Kalyabina VP, Esimbekova EN, Kopylova KV, Kratasyuk VA. Pesticides: formulants, distribution pathways and effects on human health - a review. Toxicol Rep. 2021;8:1179-1192. DOI:10.1016\/j.toxrep.2021.06.004","DOI":"10.1016\/j.toxrep.2021.06.004"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_029","doi-asserted-by":"crossref","unstructured":"Karami-Mohajeri S, Ahmadipour A, Rahimi HR, Abdollahi M. Adverse effects of organophosphorus pesticides on the liver: a brief summary of four decades of research. Arh Hig Rada Toksikol. 2017;68(4):261-275. DOI:10.1515\/aiht-2017-68-2989","DOI":"10.1515\/aiht-2017-68-2989"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_030","doi-asserted-by":"crossref","unstructured":"Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exp Suppl. 2012;101:133-164. DOI:10.1007\/978-3-7643-8340-4_6","DOI":"10.1007\/978-3-7643-8340-4_6"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_031","doi-asserted-by":"crossref","unstructured":"Lee WM. Acetaminophen-related acute liver failure in the United States. Hepatol Res. 2008;38 Suppl 1:S3-S8. DOI:10.1111\/j.1872-034X.2008.00419.x","DOI":"10.1111\/j.1872-034X.2008.00419.x"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_032","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. 2012. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/ [Accessed: 2024-08-26]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_033","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rnsson ES. Hepatotoxicity by Drugs: The Most Common Implicated Agents. Int J Mol Sci. 2016;17(2):224. DOI:10.3390\/ijms17020224","DOI":"10.3390\/ijms17020224"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_034","unstructured":"Mehta N, Ozick LA, Gbadehan E. Drug-Induced Hepatotoxicity. [Internet]. 2022. Available from http:\/\/emedicine.medscape.com\/article\/169814-overview#showall [ Accessed on: 2024-08-15]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_035","doi-asserted-by":"crossref","unstructured":"Clinton JW, Kiparizoska S, Aggarwal S, Woo S, Davis W, Lewis JH. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug Saf. 2021;44(11):1125-1149. DOI:10.1007\/s40264-021-01109-4","DOI":"10.1007\/s40264-021-01109-4"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_036","doi-asserted-by":"crossref","unstructured":"Rusyn I, Arzuaga X, Cattley RC, et al. Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity. Hepatology. 2021;74(6):3486-3496. DOI:10.1002\/hep.31999","DOI":"10.1002\/hep.31999"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_037","unstructured":"CARBON TETRACHLORIDE TOXICITY [Internet]. 2018. Available from: https:\/\/www.atsdr.cdc.gov\/csem\/carbon-tetrachloride\/toxicological_effects.html [Accessed:2024-08-12]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_038","doi-asserted-by":"crossref","unstructured":"Lau SS, Zannoni VG. Bromobenzene epoxidation leading to binding on macromolecular protein sites. J Pharmacol Exp Ther. 1981;219(2):563-572.","DOI":"10.1016\/S0022-3565(25)32840-5"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_039","doi-asserted-by":"crossref","unstructured":"Rendi\u0107 SP, Crouch RD, Guengerich FP. Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Arch Toxicol. 2022; 96(8):2145-2246. DOI:10.1007\/s00204-022-03304-3","DOI":"10.1007\/s00204-022-03304-3"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_040","doi-asserted-by":"crossref","unstructured":"ul Amin Mohsin N, Farrukh M, Shahzadi S, Irfan M. Drug Metabolism: Phase I and Phase II Metabolic Pathways [Internet]. Pharmaceutical Science. IntechOpen; 2024. Available from: http:\/\/dx.doi.org\/10.5772\/intechopen.112854 [Accessed: 2024-08-26]","DOI":"10.5772\/intechopen.112854"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_041","unstructured":"[41] Susa ST, Hussain A, Preuss CV. Drug Metabolism. [Internet]. StatPearls Publishing. 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442023\/ [ Accessed: 2024-08-26]"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_042","doi-asserted-by":"crossref","unstructured":"Choi YH, Yu AM. ABC transporters in multi-drug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des. 2014;20(5):793-807. DOI:10.2174\/1381612820 05140214165212","DOI":"10.2174\/138161282005140214165212"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_043","doi-asserted-by":"crossref","unstructured":"Zhao M, Ma J, Li M, et al. Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int J Mol Sci. 2021;22(23):12808. Published 2021 Nov 26. DOI:10.3390\/ijms222312808","DOI":"10.3390\/ijms222312808"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_044","doi-asserted-by":"crossref","unstructured":"Attia SM. Deleterious effects of reactive metabolites. Oxid Med Cell Longev. 2010;3(4):238-253. DOI:10.4161\/oxim.3.4.13246","DOI":"10.4161\/oxim.3.4.13246"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_045","doi-asserted-by":"crossref","unstructured":"Pot\u0119ga A. Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation. Molecules. 2022;27(16):5252. DOI:10.3390\/molecules27165252","DOI":"10.3390\/molecules27165252"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_046","doi-asserted-by":"crossref","unstructured":"Gunawan, B., & Kaplowitz, N. (2004). Clinical Perspectives on Xenobiotic\u2010Induced Hepatotoxicity. Drug Metabolism Reviews, 36(2), 301\u2013312. https:\/\/doi.org\/10.1081\/DMR-120034148.","DOI":"10.1081\/DMR-120034148"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_047","doi-asserted-by":"crossref","unstructured":"Allison, R., Guraka, A., Shawa, I. T., Tripathi, G., Moritz, W., & Kermanizadeh, A. (2023). Drug induced liver injury \u2013 a 2023 update. Journal of Toxicology and Environmental Health, Part B, 26(8), 442\u2013467. https:\/\/doi.org\/10.1080\/10937404.2023.2261848.","DOI":"10.1080\/10937404.2023.2261848"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_048","doi-asserted-by":"crossref","unstructured":"Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003 Jul 31;349(5):474-85. doi: 10.1056\/NEJMra021844. PMID: 12890847.","DOI":"10.1056\/NEJMra021844"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_049","doi-asserted-by":"crossref","unstructured":"Kaplowitz N. Drug-induced liver injury. Clin Infect Dis . 2004;38(Suppl 2):S44\u2013 S48. doi: 10.1086\/381446.","DOI":"10.1086\/381446"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_050","doi-asserted-by":"crossref","unstructured":"Liu Z, Que S, Xu J, Peng T. Alanine aminotransferase-old biomarker and new concept: a review. Int J Med Sci . 2014;11(9):925.","DOI":"10.7150\/ijms.8951"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_051","unstructured":"Zimmerman HJ, Maddrey WC. Toxic and drug-induced hepatitis. In: Schiff L, Schiff ER, eds. Diseases of the liver, 7th ed. Philadelphia: JB Lippincott, 1993:707\u00b183."},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_052","doi-asserted-by":"crossref","unstructured":"Katarey, D., and S. Verma. 2016. Drug-induced liver injury.Clin. Med (Northfield Il) 16:104\u201309. doi:10.7861\/clinmedicine.16-6-s104.","DOI":"10.7861\/clinmedicine.16-6-s104"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_053","doi-asserted-by":"crossref","unstructured":"Ostapowicz G, Fontana RJ, Schi\u00f8dt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137: 947-54.","DOI":"10.7326\/0003-4819-137-12-200212170-00007"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_054","doi-asserted-by":"crossref","unstructured":"Chitturi S, Farrell GC. Herbal hepatoxici ty: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000;10:1093-9. Stedman C. Herbal hepatotoxicity. Sem in Liver Dis 2002;22:195-206.","DOI":"10.1046\/j.1440-1746.2000.02349.x"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_055","doi-asserted-by":"crossref","unstructured":"Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with the di etary supplement LipoKinetix. Ann Intern Med 2002;136:590-5.","DOI":"10.7326\/0003-4819-136-8-200204160-00008"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_056","doi-asserted-by":"crossref","unstructured":"Danan G, Benichou C. Causality assess ment of adverse reactions to drugs. I. A nov el method based on the conclusions of inter national consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30.","DOI":"10.1016\/0895-4356(93)90101-6"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_057","doi-asserted-by":"crossref","unstructured":"Benichou C, Danan G, Flahault A. Cau sality assessment of adverse reactions to drugs. II. An original model for validation of drug causality assessment methods: case re ports with positive rechallenge. J Clin Epide miol 1993;46:1331-6.","DOI":"10.1016\/0895-4356(93)90102-7"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_058","doi-asserted-by":"crossref","unstructured":"Lucena MI, Camargo R, Andrade RJ, Perez-Sanchez CJ, Sanchez De La Cuesta F. Comparison of two clinical scales for causal ity assessment in hepatotoxicity. Hepatol ogy 2001;33:123-30.","DOI":"10.1053\/jhep.2001.20645"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_059","doi-asserted-by":"crossref","unstructured":"Kaplowitz N. Causality assessment ver sus guilt-by-association in drug hepatotox icity. Hepatology 2001;33:308-10.","DOI":"10.1053\/jhep.2001.21083"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_060","doi-asserted-by":"crossref","unstructured":"Marc G Sturgill, George H Lambert, Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function, Clinical Chemistry, Volume 43, Issue 8, 1 August 1997, Pages 1512\u20131526, https:\/\/doi.org\/10.1093\/clinchem\/43.8.1512.","DOI":"10.1093\/clinchem\/43.8.1512"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_061","unstructured":"Friedman LS, Martin P, Munoz SJ. Liver function tests and the objective evaluation of the patient with liver disease. In: Zakin D, Boyer TD, eds. Hepatology: a textbook of liver disease, 3rd ed. Philadelphia: WB Saunders, 1996:791\u00b1833."},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_062","unstructured":"Francis P, Navarro VJ. Drug-Induced Hepatotoxicity. 2022 Nov 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 32491467."},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_063","doi-asserted-by":"crossref","unstructured":"Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995;333: 1118\u00b127.","DOI":"10.1056\/NEJM199510263331706"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_064","doi-asserted-by":"crossref","unstructured":"Lee WM. Acute liver failure. N Engl J Med 1993;329:1862\u00b172.","DOI":"10.1056\/NEJM199312163292508"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_065","doi-asserted-by":"crossref","unstructured":"Le Dar\u00e9 B, Ferron PJ, Gicquel T. Il \u00e9tait une fois l\u2019h\u00e9patotoxicit\u00e9\u2026 [Once upon a time the hepatotoxicity\u2026]. Med Sci (Paris). 2021 Mar;37(3):235-241. French. doi: 10.1051\/medsci\/2021009. Epub 2021 Mar 19. PMID: 33739270.","DOI":"10.1051\/medsci\/2021009"},{"key":"2026070615002480558_j_prilozi-2026-0024_ref_066","doi-asserted-by":"crossref","unstructured":"Thakur S, Kumar V, Das R, Sharma V, Mehta DK. Biomarkers of Hepatic Toxicity: An Overview. Curr Ther Res Clin Exp. 2024 Apr 26;100:100737. doi: 10.1016\/j.curtheres.2024.100737. PMID: 38860148; PMCID: PMC11163176.","DOI":"10.1016\/j.curtheres.2024.100737"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2026-0024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:11:24Z","timestamp":1783350684000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2026-0024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.2478\/prilozi-2026-0024"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2026-0024","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}